Pope Leo needs no further cancer therapy, doctors say
Doctors cited localized lung adenocarcinoma after the 71-year-old pontiff’s Oct. 13 surgery. His Nov. 6–17 South America trip remains uncertain.

Pope Leo, 71, will not need further cancer therapy after Oct. 13 surgery to remove the lower lobe of his right lung, his doctors said in a Vatican statement reported Wednesday.
Evidence grade: Claim (no study cited). The update rests on the doctors’ clinical statement, not a published study, and matters because his Nov. 6-17 trip to Uruguay, Argentina and Peru is still uncertain.
The doctors said final histological examinations and molecular biology analyses of the removed tissue confirmed lung adenocarcinoma, described in the report as the most common form of lung cancer, and indicated the disease remained localized.
“A subsequent oncological evaluation has confirmed that no further therapy is required,” lead surgeon Stefano Margaritora and personal physician Luigi Carbone said, according to the Vatican statement cited by The Guardian Health.
Leo left hospital on Saturday and returned to St Peter’s Square on Wednesday for his weekly audience with pilgrims as he gradually resumes duties. Atlas360 previously reported that papal audiences had been suspended through Oct. 20 after the planned lung surgery.
The public update does not settle whether the pope can maintain next month’s travel schedule. Margaritora said last week there were “no clinical reasons” preventing travel to South America, while the Vatican’s secretary of state indicated the pontiff may need to slow the pace of his programme during recovery.
The next observable milestone is whether the Vatican confirms, revises or cancels the Nov. 6-17 itinerary for Uruguay, Argentina and Peru.
Source: news report, The Guardian Health, Oct. 21, 2026; Atlas360 background reports, Oct. 19-21, 2026.
Atlas360 reports health research and does not provide medical advice.
More stories
- Dietitians advise small swaps for plant-based eating
- TikTok dementia videos mislead in 66.4% of sample, researchers say
- Aberdeen Royal Infirmary faces police inquiry call over 19 deaths
- Bariatric surgery group loses 28.2% after GLP-1 use
- TOFA boosts mouse energy use 18% while preserving muscle
- ICO probes NHS therapy notes accessible to up to 140,000 staff
- Delayed hepatitis B dose may raise child infections 83%
- Harvard experts weigh GLP-1 priorities after 1-in-8 uptake
- RJ Mitte’s death puts cerebral palsy mental health risks in focus
- Viola Davis describes shingles pain as 9 out of 10
Latest news
- Hull City 2–0 Brighton: When Resilience Beat Reputation
- David Parr House to honor Victorian art-workman with blue plaque
- Iran's attacks hit 25 tankers near Strait of Hormuz
- FCC approves prison cellphone jamming despite 2.5-mile warning
- Russia strikes Ukraine as Odesa faces electricity strain
- Bahrain reports two injuries after Iranian aerial attacks
- Congress tests Black Democrats' growing policy influence
- Baltic responders fight Sparta II fire after drone strike

